R21/Matrix M, recently seen in news, is a new vaccine candidate for which of the following disease?
A. Malaria
B. Covid 19
C. Ebola
D. Swine flu
Explanation:
A malaria vaccine candidate has shown promise in phase 2b clinical trials, with high efficacy at 77%. The new vaccine candidate, called R21/Matrix M, is a modified version of RTS, S — another candidate against malaria that has been in development for more than 30 years by Walter Reed Institute of Research, GlaxoSmithKline and Bill and Melinda Gates Foundation with the PATH Malaria Vaccine Initiative.
